Piramal Enterprises Ltd (PEL):企業の財務・戦略的SWOT分析

◆英語タイトル:Piramal Enterprises Ltd (PEL) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2720
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Piramal Enterprises Ltd (PEL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. It also offers contract manufacturing and development services, pharma solutions, critical care solutions, imaging services, and other services such as fund management, structured investments and information management services. The company serves life sciences, financial services,health care, health care information management, specialty glass packaging and real estate sectors. It operates over 110 countries, including, India, Sri Lanka, Germany, Italy, the UK, France, Canada, the US and other countries. PEL is headquartered in Mumbai, Maharashtra, India.

Piramal Enterprises Ltd Key Recent Developments

Jul 04,2018: Ujjivan financial services limited partners with Piramal Swasthya to launch mobile primary healthcare programme in Karnataka
May 28,2018: Piramal Enterprises Limited announces Consolidated Results for the Full Year & Fourth Quarter ended 31 Mar 2018
Apr 02,2018: Piramal Enterprises Appoints Anand Piramal as Non-Executive Director on its Board
Mar 27,2018: Piramal Pharma Solutions Wins in Six Categories at the ‘CMO Leadership Awards 2018’
Jan 30,2018: Piramal Enterprises Q3 net profit up 21% at Rs 4.90 billion

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Piramal Enterprises Ltd – Key Facts 6
Piramal Enterprises Ltd – Key Employees 7
Piramal Enterprises Ltd – Key Employee Biographies 8
Piramal Enterprises Ltd – Major Products and Services 9
Piramal Enterprises Ltd – History 10
Piramal Enterprises Ltd – Company Statement 12
Piramal Enterprises Ltd – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 16
Company Overview 16
Piramal Enterprises Ltd – Business Description 17
Business Segment: Financial services 17
Overview 17
Performance 17
Key Stats 17
Business Segment: Healthcare Insights & Analytics 18
Overview 18
Performance 18
Key Stats 18
Business Segment: Outside India 18
Performance 18
Business Segment: Pharmaceuticals Manufacturing and Services 19
Overview 19
Performance 19
Key Stats 19
Geographical Segment: Eliminations 19
Performance 19
Geographical Segment: India 19
Performance 19
R&D Overview 20
Piramal Enterprises Ltd – Corporate Strategy 21
Piramal Enterprises Ltd – SWOT Analysis 22
SWOT Analysis – Overview 22
Piramal Enterprises Ltd – Strengths 22
Piramal Enterprises Ltd – Weaknesses 23
Piramal Enterprises Ltd – Opportunities 24
Piramal Enterprises Ltd – Threats 25
Piramal Enterprises Ltd – Key Competitors 26
Section 3 – Company Financial Ratios 27
Financial Ratios – Capital Market Ratios 27
Financial Ratios – Annual Ratios 28
Performance Chart 31
Financial Performance 31
Financial Ratios – Interim Ratios 32
Financial Ratios – Ratio Charts 33
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances 34
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35
Piramal Enterprises Ltd, Recent Deals Summary 36
Section 5 – Company’s Recent Developments 37
Jul 04, 2018: Ujjivan financial services limited partners with Piramal Swasthya to launch mobile primary healthcare programme in Karnataka 37
May 28, 2018: Piramal Enterprises Limited announces Consolidated Results for the Full Year & Fourth Quarter ended 31 Mar 2018 38
Apr 02, 2018: Piramal Enterprises Appoints Anand Piramal as Non-Executive Director on its Board 40
Mar 27, 2018: Piramal Pharma Solutions Wins in Six Categories at the ‘CMO Leadership Awards 2018’ 41
Mar 22, 2017: Piramal Pharma Solutions Augments Integrated Capabilities by Expanding Sterile Manufacturing Capabilities in Lexington, KY 42
Mar 20, 2017: Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer 43
Mar 15, 2017: Piramal Swasthya and National Health Mission (NHM), Govt. of Assam partnership: Citizen Health Consultations and Services for Vulnerable and Remote Communities Reach Nearly 2 crore Mark 44
Section 6 – Appendix 45
Methodology 45
Ratio Definitions 45
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Piramal Enterprises Ltd, Key Facts 6
Piramal Enterprises Ltd, Key Employees 7
Piramal Enterprises Ltd, Key Employee Biographies 8
Piramal Enterprises Ltd, Major Products and Services 9
Piramal Enterprises Ltd, History 10
Piramal Enterprises Ltd, Other Locations 13
Piramal Enterprises Ltd, Subsidiaries 13
Piramal Enterprises Ltd, Key Competitors 26
Piramal Enterprises Ltd, Ratios based on current share price 27
Piramal Enterprises Ltd, Annual Ratios 28
Piramal Enterprises Ltd, Annual Ratios (Cont...1) 29
Piramal Enterprises Ltd, Annual Ratios (Cont...2) 30
Piramal Enterprises Ltd, Interim Ratios 32
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35
Piramal Enterprises Ltd, Recent Deals Summary 36
Currency Codes 45
Capital Market Ratios 45
Equity Ratios 46
Profitability Ratios 46
Cost Ratios 47
Liquidity Ratios 47
Leverage Ratios 48
Efficiency Ratios 48

List of Figures
Piramal Enterprises Ltd, Performance Chart (2014 - 2018) 31
Piramal Enterprises Ltd, Ratio Charts 33
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34
Piramal Enterprises Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 35

★海外企業調査レポート[Piramal Enterprises Ltd (PEL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ALS Therapy Development Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary ALS Therapy Development Institute (ALS TDI), formerly ALS Therapy Development Foundation, is a drug discovery center that offers research and healthcare services. The center's pipeline product include AT-1501, a novel antibody therapeutic that blocks specific immune cell activation and prote …
  • ZoomMed Inc (ZMD):医療機器:M&Aディール及び事業提携情報
    Summary ZoomMed Inc (ZoomMed) is a technical service provider that offers web solutions for medical sectors. The company’s product includes ZoomMed Network, ZRx Prescriber, PraxisLab, and EvPsych. It builds and operates a clinical information exchange platform between physicians and specialists, pat …
  • Just the Berries Ltd:企業の戦略・SWOT・財務情報
    Just the Berries Ltd - Strategy, SWOT and Corporate Finance Report Summary Just the Berries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nippon Kayaku Co., Ltd.:企業の戦略・SWOT・財務情報
    Nippon Kayaku Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Kayaku Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Leonardo UK Ltd:企業の戦略・SWOT・財務情報
    Leonardo UK Ltd - Strategy, SWOT and Corporate Finance Report Summary Leonardo UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Next Fifteen Communications Group plc:企業のM&A・事業提携・投資動向
    Next Fifteen Communications Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Next Fifteen Communications Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Nonin Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nonin Medical Inc (Nonin) is a medical device company that provides medical monitoring solutions. The company provides noninvasive physiological monitoring devices for health professionals and consumers. Its products include pulse oximeters and sensors, regional oximeters and sensors, finger …
  • TransAlta Corporation:企業の戦略・SWOT・財務情報
    TransAlta Corporation - Strategy, SWOT and Corporate Finance Report Summary TransAlta Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Yellowstone Valley Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Yellowstone Valley Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Bisalloy Steel Group Ltd:企業の戦略・SWOT・財務分析
    Bisalloy Steel Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Bisalloy Steel Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Consolidated Edison Solutions Inc:企業の戦略的SWOT分析
    Consolidated Edison Solutions Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Nimbus Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Nimbus Therapeutics LLC (Nimbus Therapeutics), formerly Nimbus Discovery LLC, is a biotechnology company that develops medicines for critical diseases such as metabolic disease, cancer, and immune-inflammatory disorders. The company harnesses its expertise in deep computational chemistry to …
  • Surgutneftegas (SNGS):企業の財務・戦略的SWOT分析
    Surgutneftegas (SNGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • AMCON Distributing Company:企業の戦略・SWOT・財務情報
    AMCON Distributing Company - Strategy, SWOT and Corporate Finance Report Summary AMCON Distributing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • G4S Plc (GFS):企業の財務・戦略的SWOT分析
    G4S Plc (GFS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • SecureWorks Corp (SCWX):企業の財務・戦略的SWOT分析
    SecureWorks Corp (SCWX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • BP Plc (BP.)-石油・ガス分野:企業M&A・提携分析
    Summary BP p.l.c. (BP) is an integrated oil and gas company. It provides fuel, energy, lubricants and petrochemicals to its customers. Its upstream activities include oil and natural gas exploration, field development and production; and midstream operations include transportation, and marketing and …
  • JGC Corporation (1963):電力:M&Aディール及び事業提携情報
    Summary JGC Corporation (JGC) is an engineering contracting company. It offers engineering, procurement and construction services for various engineering contracts and projects in the areas of oil and gas development, petroleum refining, natural gas processing, petrochemicals, clean energy and power …
  • Haplogen GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Haplogen GmbH (Haplogen) is a biopharmaceutical company that improves human health by fighting against infectious diseases such as common cold, dengue fever, influenza and hepatitis C. The company utilizes its proprietary genetics technology platform to identify novel pathogen host factors a …
  • Novo Nordisk AS (NOVO B):企業の財務・戦略的SWOT分析
    Novo Nordisk AS (NOVO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆